Prostate Cancer - Results from #24520

Advances in the treatment of prostate cancer - dawn of a new era - Abstract October 25, 2012

First web-based prostate cancer database launches to help new patients manage care, avoid complications October 24, 2012

Why are diabetics at reduced risk for prostate cancer? A review of the epidemiologic evidence - Abstract October 24, 2012

Contemporary role of systematic prostate biopsies: Indications, techniques, and implications for patient care - Abstract October 24, 2012

Noninvasive assay monitored treatment response in patients with metastatic prostate cancer October 24, 2012

Thromboembolic events following surgery for prostate cancer - Abstract October 24, 2012

The REDUCE Follow-up Study: Low rate of new prostate cancer diagnoses observed during a 2-year, observational, follow-up study of men who participated in the REDUCE (REduction by DUtasteride of prostate Cancer Events) trial - Abstract October 24, 2012

Risk and prevention of acute urinary retention after robotic prostatectomy - Abstract October 24, 2012

The number of cores taken is a major predictor of insignificant prostate cancer in patients diagnosed with a single microfocus at initial biopsy: Implications for the selection of candidates suitable for active surveillance - Abstract October 24, 2012

Nutrition education for osteoporosis prevention in men with prostate cancer initiating androgen deprivation therapy - Abstract October 24, 2012

Alcohol consumption and PSA-detected prostate cancer risk - a case-control nested in the ProtecT study - Abstract October 24, 2012

Screening and early diagnosis of prostate cancer: an update October 23, 2012

Abiraterone and novel antiandrogens: Overcoming castration resistance in prostate cancer - Abstract October 23, 2012

Prognostic prediction following radical prostatectomy for prostate cancer using conventional as well as molecular biological approaches - Abstract October 23, 2012

Zinc α2-glycoprotein as a potential novel urine biomarker for the early diagnosis of prostate cancer - Abstract October 23, 2012

Effect of metabolic syndrome on pathologic features of prostate cancer - Abstract October 23, 2012

Two-year survival follow-up of the randomized, double-blind, placebo-controlled phase II study of radium-223 chloride in patients with castration-resistant prostate cancer and bone metastases - Abstract October 23, 2012

Personal preferences and discordant prostate cancer treatment choice in an intervention trial of men newly diagnosed with localized prostate cancer - Abstract October 23, 2012

Validation of normal tissue complication probability predictions in individual patient: Late rectal toxicity - Abstract October 23, 2012

Do prostate cancer patients suffer more from depressed mood or anhedonia? - Abstract October 23, 2012

Page 1227 of 1435